Zobrazeno 1 - 10
of 64
pro vyhledávání: '"Jianrong Wu"'
Autor:
Yini Chen, Jianrong Wu, Hairong Liu, Yan Wang, Yuanyi Zheng, Bing Hu, Junnian Hao, Jian Shen, Xiaojun Cai
Publikováno v:
Journal of Nanobiotechnology, Vol 19, Iss 1, Pp 1-16 (2021)
Journal of Nanobiotechnology
Journal of Nanobiotechnology
Background The risk of local recurrence after high-intensity focused ultrasound (HIFU) is relatively high, resulting in poor prognosis of malignant tumors. The combination of HIFU with traditional chemotherapy continues to have an unsatisfactory outc
Autor:
M. Beth McCarville, Alberto S. Pappo, Kirsten K. Ness, Christopher L. Tinkle, Matthew J. Krasin, Barry L. Shulkin, Jianrong Wu, Thomas E. Merchant, Chia-Ho Hua, Armita Bahrami, Sue C. Kaste, Sheri L. Spunt, Shenghua Mao, Andrew M. Davidoff, Daniel M. Green
Publikováno v:
Int J Radiat Oncol Biol Phys
PURPOSE: Our purpose was to assess disease outcomes and late toxicities in pediatric patients with rhabdomyosarcoma treated with conformal photon radiation therapy (RT). METHODS AND MATERIALS: Sixty-eight patients (median age, 6.9 years) were treated
Publikováno v:
Theranostics
The hypoxia of the tumor microenvironment (TME) often hinders the effectiveness of cancer treatments, especially O2-dependent photodynamic therapy (PDT). Methods: An integrated iridium oxide (IrO2)-manganese dioxide (MnO2) nanotheranostic agent was f
Autor:
Jianrong Wu, Jing Wei
Publikováno v:
Stat Med
Cancer immunotherapy trials have two special features: a delayed treatment effect and a cure rate. Both features violate the proportional hazards model assumption and ignoring either one of the two features in an immunotherapy trial design will resul
Autor:
Jianrong Wu, Jing Wei
Publikováno v:
Stat Med
Immunotherapies are increasingly used for treating patients with advanced-stage cancers. However, cancer immunotherapy trials often present delayed treatment effects and long-term survivors which result non-proportional hazard models and challenge th
Autor:
Xiaojun Cai, Ziliang Dong, Zhuang Liu, Jianrong Wu, Yuanyi Zheng, Junnian Hao, Liangzhu Feng, Jienan Wang, Guofeng Shen, Tao Ying, L.W. Wang
Publikováno v:
Advanced materials (Deerfield Beach, Fla.). 33(51)
Fast and effective thrombolysis using tissue plasminogen activator (tPA) is limited by the poor delivery efficiency of thrombolytic drugs, which is induced by an interrupted bloodstream and delayed recanalization. Existing magnetic micro/nanodrug-loa
Autor:
Jianrong Wu
Publikováno v:
Single-Arm Phase II Survival Trial Design
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5adff7a0849370f5d13b29d0f9b3aa53
https://doi.org/10.1201/9781003129059-7
https://doi.org/10.1201/9781003129059-7
Publikováno v:
Journal of Nanobiotechnology, Vol 19, Iss 1, Pp 1-14 (2021)
Journal of Nanobiotechnology
Journal of Nanobiotechnology
BackgroundsPhotothermal therapy (PTT) inducing localized hyperthermia to kill cancer cells has attracted wide attention in cancer therapy. The production of reactive oxygen species (ROS) during photothermal therapy (PTT) may cause irreversible damage
Autor:
Noelle L. Williams, Sue C. Kaste, Jamie E. Flerlage, Huiyun Wu, Christopher L. Tinkle, Melissa M. Hudson, Monika L. Metzger, Aimee C Talleur, Jianrong Wu, Barry L. Shulkin, Matthew J. Krasin
Publikováno v:
Radiother Oncol
Background and purpose The use of radiotherapy (RT) for pediatric patients with Hodgkin lymphoma (HL) experiencing disease progression or recurrence (15%) is controversial. We report treatment patterns and outcomes for pediatric patients with refract
Publikováno v:
Colloids and Surfaces B: Biointerfaces. 173:101-108
Molybdenum disulfide (MoS2) has been extensively explored for biomedical applications due to its excellent photothermal conversion ability. In this paper, we report a nanoplatform based on folic acid (FA) targeted dual-stimuli responsive MoS2 nanoshe